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EXECUTIVE SUMMARY INTRODUCTION
Definition
• Novel Psychoactive Substances (NPS) are chemical substances that have 
been synthesised to cause similar reactions to those produced by taking 
conventional drugs. The concern surrounding use of NPS is a relatively re-
cent phenomenon.
• It is estimated that there are 14,135 NPS users in South Gloucestershire 
aged between 16 and 59. In addition, it is estimated that the theoretical 
maximum number of NPS users in South Gloucestershire, who may also 
require intervention treatment is 1343 users.
• The local treatment data in 2012/2013 and 2013/2014 show that there 
were 28 unique clients who cited NPS as primary drug use and another 19 
cited NPS as secondary drug use. There are gaps and unmet needs within 
the local treatment system in dealing with NPS users, which are not appar-
ent on the surface.
• The challenges of the NPS in the South Gloucestershire area are fourfold: 
Public Health concerns; data collection and intelligence; dealing with crime 
and anti-social behavior and increasing community confidence; and con-
sumer protection.
• There are four potential workstreams that can be undertaken for the NPS 
Project, including enhancing awareness through education and training, fa-
cilitating intelligence sharing through robust data collection, reducing harm 
to the local communities, and signposting the users who require further 
treatment intervention into the community treatment system.
Novel Psychoactive Substances (hereinafter ‘NPS’, a term also often referred 
to as ‘legal highs’) are chemical substances that have been synthesised to 
cause similar reactions to those produced by taking conventional drugs, which 
are controlled under the Misuse of Drugs Act 1971. 
These chemical substances are newly created, and hence, are not automati-
cally controlled under relevant legislations. 
The concern surrounding use of NPS is a relatively recent phenomenon. Prior 
to the rapid growth in the consumption of mephedrone in late 2009, NPS were 
not widely recognised as a concern within the substance misuse environment. 
However, circa 236 types of NPS were formally identified and logged on the 
European Monitoring Centre for Drugs and Drug Addiction’s (EMCDDA) early 
warning system by the end of 2012.1
These findings, coupled with continual media coverage, have made the NPS 
use the latest public health concern.
1European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), ‘Introduction to the Topic of New Drugs (New Psycho-
active Substances)’ (May 2013).
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GOVERNING POLICIES
LOCAL PREVALENCE
Regulatory and Legal Framework
Estimating the Prevalence of NPS in South 
Gloucestershire
The South Gloucestershire NPS Project is underpinned by the following gov-
erning policies:
• The Government 2010 Drug Strategy, ‘Reducing Demand, Restricting Sup-
ply, Building Recovery: Supporting People to Live a Drug-free Life’, high-
lights the need to respond to emerging drug threats and tackle drug de-
pendence.2 This includes improving research and analytical capabilities to 
identify these substances and strengthen law enforcement action.
• Building Recovery in Communities 2011 enshrines the value of working 
with people who wish to take proactive steps in tackling their dependency 
on substance misuse, and offers an exit strategy through recovery.3
• Annual Review of the Drug Strategy 2012 specifies action plans to tackle 
the NPS market, which comprises collaborative working in response to 
NPS and improving their monitoring, research, analysis, and forensic ca-
pability.
• Localism Act 2011 – This is an act that provides freedom to shape the 
treatment in line with the Localism agenda, where the working model is 
based on the experience and understanding of local evidence, and is ap-
propriate to the context and population of South Gloucestershire.
Given the stigma associated with substance misuse and the nature of some 
drugs, it is difficult to accurately estimate the scale of the NPS problem in 
South Gloucestershire. Nevertheless, the following predictive analysis meth-
odologies have been employed to evaluate the scale and complexity of NPS 
use within the local area:
• The data from the British Crime Survey (BCS) 2013 has been used to esti-
mate the prevalence of NPS in South Gloucestershire.4
• Using capture-recapture method, the percentages of prevalence of NPS 
use among those aged 16 - 59 have been used as mean percentages to 
estimate the theoretical maximum number of local NPS users. 
These mean percentages are multiplied by the total population of South 
Gloucestershire aged 16 – 59, which is 157,502.5
Table 1: Theoretical Maximum of 16 to 59 Year Old Reporting Use of Illicit Drugs in the Last Year
2HM Government, ‘Drug Strategy 2010: Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a 
Drug Free Live’ (2010).
3National Treatment Agency for Substance Misuse (NTA), ‘Building Recovery in Communities: A Summary of the Responses to 
the Consultation’ (2012).
4Home Office Statistical Bulletin, ‘Findings from the 2012 to 2013 Crime Survey for England and Wales’ (July 2013). The BCS is 
a nationally representative survey in which residents in households in England and Wales are asked about illicit drug use, which 
involved 28,000 respondents aged 16 – 59. BCS estimates are based on a sample of the population, which is considered large 
for a government survey. Published figures and comparisons are considered to be robust with 93% response rate for the illicit 
drug questions. Data are weighted to ensure figures are as representative of the population as possible.
5Office for National Statistics, ‘Mid-2012 Population Estimates: Single Year of Age and Sex for Local Authorities in England and 
Wales’ (June 2013).
Types of Drug Mean Percentages of 
Estimated Drug Use (%)
Theoretical Maximum 
Number of NPS Users in 
South Gloucestershire
Salvia 0.3 473
Nitrous oxide 2 3150
Amyl nitrite 0.8 1197
Mephedrone11 (Class B) 0.5 835
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• Using the table above, we can see that there are at least 5,655 NPS users 
in South Gloucestershire. It is noted that there are only four types of drugs 
that were featured in BCS as detailed in Table 1 above, whilst there are 
ten popular NPS6 in the market.  Therefore, theoretical maximum figures to 
represent all of the ten drugs are derived using algebraic fractions.
Using this statistical model, it is suggested that there are 14,135 NPS 
users in South Gloucestershire aged between 16 and 59.7
Within this cohort, there is a proportion of NPS users who use drugs in a 
problematic way, and may require intervention treatment. To obtain the num-
ber of these users:
• The output from the prevalence estimates above is further stratified by 
the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
estimate. The output will enable the substance misuse commissioners of 
the local treatment system to obtain the number of NPS users who are yet 
to engage with the local treatment system. 
• The EMCDDA estimate of drug use is between 9.1% and 9.9%, and it 
has been decided that the median (9.5%) should be used for calculation 
purposes. 
Using this formula, it is suggested that the theoretical maximum num-
ber of NPS users in South Gloucestershire, who may also require inter-
vention treatment is 1343 users.
6Based on an official list by the Advisory Council on the Misuse of Drugs (ACMD). The list includes Nitrous Oxide (Laughing 
Gas), Solvent, Poppers (Amyl Nitrate), Salvia (Plants/Fungi), Benzylpiperazine (BZP), Gammahydroxybutrate (GHB), SPICE, 
Mephedrone, Naphyrone (NRG1) and Ivory Wave.
7Since this is based on a count of individuals, an individual may appear in more than one drug category, indicating poly-drug 
users within the local population.
Treatment Data 2012/2013 and 2013/2014
The local treatment data in 2012/2013 and 2013/2014 show that there were 
28 unique clients who cited NPS as primary drug use (mephedrone) and an-
other 19 cited NPS as secondary drug use.8
Comparing these findings with the estimated prevalence of NPS use in the 
earlier section, the inference suggests that there are gaps and unmet needs 
within the local treatment system in dealing with NPS users, which are not 
apparent on the surface.
The profile of service users who cited NPS as their primary and secondary 
drug use is available overleaf.
CURRENT LOCAL PROFILE
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CHALLENGES
Estimating the Prevalence of NPS in South 
Gloucestershire
The lack of information on the risks associated with the NPS has given a false 
sense of safety to the public. 
The primary source of information on the health harms related to NPS is from us-
ers presenting to hospital emergency departments with acute toxicity. There have 
been reports related to Mephedrone toxicity9, Ivory Wave toxicity10 and general 
NPS toxicity11, which found that patients generally present with a range of symp-
toms including tachycardia, palpitations, agitation, anxiety, hypertension, lack of 
coordination and reduced conscious levels.
The presentation to the healthcare establishments, comes with the inevitable 
economic costs. On average, a person who requires a primary care intervention 
will incur £1,025, based on the following average costs:
• Emergency ambulance call-out – £244 per call
• Accident and Emergency (A&E) attendance - £100 per attendance
• Occupation of a hospital bed - £569 per night
• Cost of treatment provided - £112 per visit.12
The majority of admissions for NPS cases require a minimum of one night occu-
pying a bed whilst waiting for the effects to subside; therefore this would be a 
minimum cost.  This does not include the costs if the individual requires treatment 
from substance misuse services.
Nationally, there were 52 deaths recorded based on the underlying cause of 
drug-related poisoning and an NPS was specified on the death certificate; three 
of these deaths happened in the South West region.13
9James, D. et al., ‘Clinical Characteristics of Mephedrone Toxicity Reported to the UK National Poisons Informa-
tion Service’ [2010] 28(8) Emergency Medical Journal 686
10Murray, D. et al., ‘Ivory Wave Toxicity in Recreational Drug Users; Integration of Clinical and Poisons Information 
Services to Manage Legal High Poisoning’  [2012] 50(2) Clinical Toxicology 108  
11Wood, D. M. and Dargan, P. I., ‘Mephedrone (4-methylmethcathinone): What is New in Our Understanding of its 
Use and Toxicity?’ [2012] Progress in Neuro-Psychopharmacology & Biological Psychiatry 1.
12Estimated costs provided by the Leicestershire Substance Misuse Partnerships 2013.
13Office for National Statistics, ‘Deaths Related to Drug Poisoning in England and Wales 2012’ (2013).
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Data Collection and Intelligence
Data Collection and Criminal 
Justice and Community Confi-
dence Intelligence
Trading Standards and Consumer Protection
NPS use is complex and fluid. Keeping abreast of the new development of the NPS 
is pivotal to the local treatment system to avoid intelligence from being redundant. 
At the same time, reliance on precaution-
ary principle is desirable. The lack of under-
standing and knowledge of the effects of 
NPS are not a reason to not provide health 
interventions.
Local data collection will be an asset to en-
hance understanding the issues and chal-
lenges faced in tackling NPS.
The intelligence on the NPS can be used to encourage enforcement activities by 
Trading Standards, when offences under the Consumer Protection from Unfair 
Trading Regulations 2008 and the General Product Safety Regulations 2005 are 
suspected, often because of mis-description of products. 
Often, the display of NPS includes the disclaimer, ‘not fit for human consumption’ 
and thus, can be sold and purchased legally. 
The Trading Standards of South Gloucestershire Council have not received many 
complaints or intelligence about the sup-
ply of NPS products in the local area, 
which suggests either the lack of em-
powerment or information to increase in 
reporting, or that the NPS products are 
often obtained through online mediums. 
Either way, the substance misuse ac-
tors, along with Trading Standards and 
in partnership with the local police, will 
have a role in relation to policing head 
shops that sell NPS through consumer 
protection agenda.
The use of NPS and its effects are not only 
confined to the health and wellbeing sphere; 
it is transcended across other interface ser-
vices, such as the criminal justice system 
and community confidence.
In Avon and Somerset area, drugs remain primary drivers of demand in responding 
towards crime and anti-social behaviour. The harm related to the use of legal highs 
continues to drive risk and concern amongst vulnerable communities in Avon and 
Somerset area, particularly in facilitating organised criminal activities.14
In addition, there is a strong correlation between the use of NPS and the level of 
anti-social behaviour cases and the night-time economy in a local area, as evi-
denced in other areas as well, such as Oldham and Huddersfield, through Opera-
tion Burdock by the Metropolitan Police Service.
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WORKING HYPOTHESES
Predicting the Local Picture of NPS
• The demographic profile of the majority of NPS service users consist of 
the following characteristics: under 30s, male, not a parent and reside 
within the priority neighbourhood areas of South Gloucestershire.
• The majority of those who are using NPS are in full-time education, and 
are followed by those who are in full-time employment.15
• NPS can be easily obtained from various business establishments. Pur-
chases of such products through the Internet, are not uncommon.
• There is a strong correlation between those attending night clubs within 
the night-time economy and using NPS.16
• Consumption of novel psychoactive substances appears to be more 
prevalent outside major towns and cities, in areas where it is more diffi-
cult to acquire conventional drugs. In this context, the use of NPS may 
be more prevalent in South Gloucestershire compared to its neighbour-
ing authorities.17
• There is potential presence of NPS, along with other illegal substances, 
at music and dance festivals. 
• The majority of the service users will cease to use NPS if severe health 
consequences, including deaths, are reported.18
15See footnote 17 above.
16See footnote 4 above. Use of mephedrone was 20 times higher amongst those who had visited nightclubs four or more times 
within the past month (4.4%) compared with those who had not visited nightclubs within the last month (0.2%).
17House of Commons – Home Affairs Committee, ‘Drugs: New Psychoactive Substances and Prescription Drugs – Twelfth Re-
port of Session 2013 – 14’ (2013).
18NME Drugs Survey (October 2013).
EXPECTATION 
ON THE NPS PROJECT
The workstreams may include, but are not limited to, the following:
Enhancing awareness through education and training
• Increase awareness and understanding of the risks associated with the 
use of NPS across South Gloucestershire’s communities through the 
use of appropriate public health awareness campaigns and initiatives. 
• Enhance understanding of NPS through the delivery of training pro-
grammes to the professionals and the development of robust multi-agen-
cy strategic and operational communication pathways to ensure the ef-
fective collation, recording, and sharing of information.
• Ensure best use of technology in relation to the dissemination of infor-
mation linked to NPS including social media, social networking sites, 
smartphone applications, texting, and radio campaigns.
Data col lection and intel l igence sharing
• Establish a formal data collation and information sharing framework, re-
lating to NPS for the purpose of localised needs assessment, local in-
telligence, and coordinating direction of future operational and strategic 
delivery.
• Facilitate communication and information sharing with partners and 
stakeholders in the event of an untoward incident relating to NPS and 
Club Drugs, which is inclusive of, but not limited to, the following: South 
Gloucestershire Council’s Departments, Public Health England, Avon & 
Somerset Constabulary, Avon & Somerset Probation Trust, adult and 
young people’s treatment providers, service user groups, GP practices, 
Clinical Commissioning Group (CCG), LCG’s and Mental Health services.
Potential Workstreams
16 17
Reducing harm to the local communit ies
• Work in conjunction with A&E Departments and Ambulance Services to 
ensure the effective recording and collation of data for presentations re-
lated to NPS use including patterns of acute toxicity. 
• Work in conjunction with health services such as GP surgeries, pharma-
cies, hospitals and sexual health providers to ensure the effective dis-
semination of public health awareness messages linked to NPS use.
• Provision of brief interventions to reduce or stop use, localised on-site 
advice and help at festivals, clubs and other environments with a high 
likelihood of use.
Signposting into the local treatment system
• Use the existing substance misuse referral pathways by signposting us-
ers who require treatment to aid the reporting of non-opiate and crack 
users to the NDTMS.
DEMONSTRATING 
EFFECTIVENESS
Performance Framework of the Project
Outputs
There are many, if not all, publications that call for better monitoring, but 
often omitted what should be monitored to aid an understanding the scale 
of the NPS use in the local area. In this context, the South Gloucestershire 
NPS Project will have the opportunity to fulfil the knowledge gaps in this 
area. 
The potential outputs of the project will include the following:
• Types of NPS used
• Usage with other substances
• Motivation of use
• Methods of consumption
• Methods of obtaining the substances
• Frequency of use
• Concurrent health-related and other behaviours
• Outcomes of use, such as acute harm, toxicity, or dependency
• Demographic patterns of the service users
• Collection of full postcodes of the service users to determine the prev-
alence of NPS within certain wards, particularly in the neighbourhood 
priority areas
• Signposting to the community treatment services
• Service users’ satisfaction with the project
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Outcomes
It is also anticipated that the project may demonstrate the following out-
comes:
• Evidence of positive outcomes for service users, particularly on the 
recovery
• Signposting into the treatment system and appropriate support ser-
vices for those who require further interventions
• Availability of support towards parents and concerned others who are 
affected by the NPS use
• Better data collection and information sharing, to inform operational 
and strategic decision-making of the DAAT and its partner organisa-
tions
• Increased public awareness and understanding of the community on 
the NPS use, associated harms and the availability of advice, informa-
tion, and support
• Increased staff confidence across all services, particularly health, crim-
inal justice and consumer protection, to identify and respond to NPS 
use on presentation 
• Reduced incidences of overdose, hospital admissions and paramedic 
call outs linked to NPS in South Gloucestershire
• Increased awareness of the local intelligence picture in relation to NPS 
within the county including identification of ‘Head Shop’ suppliers
• Availability of consumer profiling to determine the use of NPS within 
South Gloucestershire and the needs of wider health determinants
• Evidence positive outcomes for individuals and demonstrate good val-
ue for the money
